Evidence map›Paper›PMID 40491436›Full record

ArticleFrontiers in cellular and infection microbiology2025

Long-term alterations in gut microbiota following mild COVID-19 recovery: bacterial and fungal community shifts.

Da Li, Da-Ya Zhang, Shi-Ju Chen, Yan-Ting Lv, Shi-Mei Huang, Chen Chen, Fan Zeng, Run-Xiang Chen, Xiao-Dong Zhang, Jian-Xin Xiong and 8 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Da LiThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Da-Ya ZhangThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Shi-Ju ChenThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Yan-Ting LvThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Shi-Mei HuangThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Chen ChenThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Fan ZengThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Run-Xiang ChenThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Xiao-Dong ZhangThe Second School of Clinical Medicine, Hainan Medical University, Haikou, China.
Jian-Xin XiongDepartment of Gastroenterology, Hainan Second People's Hospital, Wuzhishan, China.
Fa-Di ChenDepartment of Gastroenterology, Wuzhishan Center for Disease Control and Prevention, Wuzhishan, China.
Yue-Hong JiangDepartment of Gastroenterology, The Second People 's Hospital of Ledong Li Autonomous County, Ledong Li Autonomous County, China.
Zhai ChenDepartment of Gastroenterology, Dongfang People's Hospital, Dongfang, China.
Cui-Yi MoDepartment of Gastroenterology, Qionghai People's Hospital, Qionghai, China.
Jia-Jia ChenDepartment of Gastroenterology, Qionghai People's Hospital, Qionghai, China.
Xu-Li ZhuDepartmenrt of Internal Medicine, Otog Front Banner People 's Hospital, Otog Front Banner, China.
Li-Jun ZhangHealth Management Center, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Fei-Hu BaiDepartment of Gastroenterology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: COVID-19 has had a profound impact on public health globally. However, most studies have focused on patients with long COVID or those in the acute phase of infection, with limited research on the health of individuals who have recovered from mild COVID-19. This study investigates the long-term changes in bacterial and fungal communities in individuals recovering from mild COVID-19 and their clinical relevance. Methods: Healthy individuals from Hainan Province were enrolled before the COVID-19 outbreak, along with individuals recovering from COVID-19 at 3 months and 6 months post-recovery. Stool, blood samples, and metadata were collected. Metagenomic sequencing and Internal Transcribed Spacer (ITS) analysis characterized bacterial and fungal communities, while bacterial-fungal co-occurrence networks were constructed. A random forest model evaluated the predictive capacity of key taxa. Results: The gut microbiota of COVID-19 recoverees differed significantly from that of healthy individuals. At 3 months post-recovery, probiotics (e.g., Conclusion: These findings highlight the significant long-term impacts of mild COVID-19 recovery on gut microbiota, with key taxa influencing metabolism and immune regulation, supporting microbiome-based strategies for recovery management.

Indexed as

BacteriaCOVID-19FungiGastrointestinal MicrobiomeMycobiomeAdultChinaFecesFemaleHumansMaleMetagenomicsMiddle AgedProbioticsSARS-CoV-2bacterial-fungal co-occurrence networkfungal microbiotagut microbiomemetagenomic sequencingmild COVID-19probioticsrandom forest modelROC curve analysis

Identifiers

PMID40491436
PMCPMC12146308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.